home.social

#tumour — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #tumour, aggregated by home.social.

  1. Mapping the gut bacteria linked to colorectal cancer | News | CORDIS

    A large-scale analysis reveals a robust gut microbiome signature for colorectal cancer, paving the way for new dietary…
    #Europe #EU #EuropeanCommission #CartoHostBug #colorectalcancer #gut #gutmicrobiome #lesion #microbialsignature #Microbiome #tumour
    europesays.com/europe/122794/

  2. AstraZeneca wins EU tumour‑agnostic nod for Enhertu | AZN SEC Filing

    FORM 6-K   SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Report of Foreign Issuer   Pursuant…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #antibodydrugconjugate #AZN #DaiichiSankyo #DESTINY-PanTumor02 #EnhertuEUapproval #Oncology #tumour-agnosticHER2therapy
    europesays.com/britain/72846/

  3. Brain tumour campaign for Bryan raises over £69k in 24 hours

    A CAMPAIGN to raise £150,000 for well-known local figure Bryan Peterson’s brain tumour treatment has raised over £69,000…
    #NewsBeep #News #Health #Brain #Bryan #GB #Peterson #research #tumour #UK #UnitedKingdom
    newsbeep.com/uk/489852/

  4. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  5. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  6. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  7. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  8. Scientists have developed a simple DNA blood test
    that can predict how well patients with breast cancer will respond to treatment.

    More than 2 million people globally each year are diagnosed with the disease,
    which is the world’s most prevalent cancer.
    Although treatments have improved in recent decades, it is not easy to know which ones will work best for which patients.
    Now researchers have designed a #liquid #biopsy that tells doctors how likely a patient is to respond to a specific treatment -- even before it begins.

    The test has the potential to be gamechanging because it means patients could be offered alternative options, and avoid treatments that won’t help them, boosting their chances of beating the disease.

    The test, developed by a team at the Institute of Cancer Research, London (ICR),
    analyses #circulating #tumour #DNA (ctDNA), which is released into the blood of patients by cancer cells.
    Researchers measured these microscopic levels of cancer DNA in blood samples from 167 patients.
    The test was trialled before treatment began and again four weeks later, after a single treatment cycle.
    There was a strong association between low levels of ctDNA at the start of treatment, and treatment response, according to the team.
    A similar association was seen with the results taken at four weeks.
    theguardian.com/science/2026/j

  9. "Researchers from RMIT University in Australia and Indian institutions unveiled a novel gold-based drug that shows significant promise in the fight against cancer. The drug has demonstrated the ability to slow #tumour growth while selectively targeting cancer cells more effectively than traditional #chemotherapy agents."
    interestingengineering.com/hea

  10. "Researchers from RMIT University in Australia and Indian institutions unveiled a novel gold-based drug that shows significant promise in the fight against cancer. The drug has demonstrated the ability to slow #tumour growth while selectively targeting cancer cells more effectively than traditional #chemotherapy agents."
    interestingengineering.com/hea

  11. "Researchers from RMIT University in Australia and Indian institutions unveiled a novel gold-based drug that shows significant promise in the fight against cancer. The drug has demonstrated the ability to slow #tumour growth while selectively targeting cancer cells more effectively than traditional #chemotherapy agents."
    interestingengineering.com/hea

  12. "Researchers from RMIT University in Australia and Indian institutions unveiled a novel gold-based drug that shows significant promise in the fight against cancer. The drug has demonstrated the ability to slow #tumour growth while selectively targeting cancer cells more effectively than traditional #chemotherapy agents."
    interestingengineering.com/hea

  13. "Researchers from RMIT University in Australia and Indian institutions unveiled a novel gold-based drug that shows significant promise in the fight against cancer. The drug has demonstrated the ability to slow #tumour growth while selectively targeting cancer cells more effectively than traditional #chemotherapy agents."
    interestingengineering.com/hea

  14. "By using time-resolved analyses of scRNA-seq data, we determined the potential transitional trajectories of tumor cells and identified the metastasis-initiating subpopulations"

    link.springer.com/article/10.1

    Reading right now. The identification of cells that initiate #metastasis are of interest, although n=2 paired primary and #BoneMarrow samples may be a bit limited.

    #scRNAseq #tumour #Neuroblastoma #pseudotime

  15. "By using time-resolved analyses of scRNA-seq data, we determined the potential transitional trajectories of tumor cells and identified the metastasis-initiating subpopulations"

    link.springer.com/article/10.1

    Reading right now. The identification of cells that initiate #metastasis are of interest, although n=2 paired primary and #BoneMarrow samples may be a bit limited.

    #scRNAseq #tumour #Neuroblastoma #pseudotime

  16. "By using time-resolved analyses of scRNA-seq data, we determined the potential transitional trajectories of tumor cells and identified the metastasis-initiating subpopulations"

    link.springer.com/article/10.1

    Reading right now. The identification of cells that initiate #metastasis are of interest, although n=2 paired primary and #BoneMarrow samples may be a bit limited.

    #scRNAseq #tumour #Neuroblastoma #pseudotime

  17. "By using time-resolved analyses of scRNA-seq data, we determined the potential transitional trajectories of tumor cells and identified the metastasis-initiating subpopulations"

    link.springer.com/article/10.1

    Reading right now. The identification of cells that initiate #metastasis are of interest, although n=2 paired primary and #BoneMarrow samples may be a bit limited.

    #scRNAseq #tumour #Neuroblastoma #pseudotime

  18. @photography

    Ania, National Cancer Institute, Kyiv, 2015

    “Ania is a six-year-old girl who grew up in a small town outside the exclusion zone. People who grew up in the contaminated areas are having #children, and there’s a lot of genetic mutation and illness related to radiation. Ania was suffering from a malignant bone #tumour. She was a strong, positive child, passionate about art and drawing. The doctors told me she had little hope of survival. I don’t know if she is still alive or not.”

  19. @photography

    Ania, National Cancer Institute, Kyiv, 2015

    “Ania is a six-year-old girl who grew up in a small town outside the exclusion zone. People who grew up in the contaminated areas are having #children, and there’s a lot of genetic mutation and illness related to radiation. Ania was suffering from a malignant bone #tumour. She was a strong, positive child, passionate about art and drawing. The doctors told me she had little hope of survival. I don’t know if she is still alive or not.”

  20. @photography

    Ania, National Cancer Institute, Kyiv, 2015

    “Ania is a six-year-old girl who grew up in a small town outside the exclusion zone. People who grew up in the contaminated areas are having #children, and there’s a lot of genetic mutation and illness related to radiation. Ania was suffering from a malignant bone #tumour. She was a strong, positive child, passionate about art and drawing. The doctors told me she had little hope of survival. I don’t know if she is still alive or not.”

  21. @photography

    Ania, National Cancer Institute, Kyiv, 2015

    “Ania is a six-year-old girl who grew up in a small town outside the exclusion zone. People who grew up in the contaminated areas are having #children, and there’s a lot of genetic mutation and illness related to radiation. Ania was suffering from a malignant bone #tumour. She was a strong, positive child, passionate about art and drawing. The doctors told me she had little hope of survival. I don’t know if she is still alive or not.”

  22. @photography

    Ania, National Cancer Institute, Kyiv, 2015

    “Ania is a six-year-old girl who grew up in a small town outside the exclusion zone. People who grew up in the contaminated areas are having #children, and there’s a lot of genetic mutation and illness related to radiation. Ania was suffering from a malignant bone #tumour. She was a strong, positive child, passionate about art and drawing. The doctors told me she had little hope of survival. I don’t know if she is still alive or not.”

  23. Fitness has always been a center-point of my life, a magnet which brought together the vastness of inner worlds and anchored them to the physical form. I could never desire a life without those abilities: climbing ice and rock, backcountry telemark, riding and racing, or simply exploring the beauty of nature.

    Then, perhaps I pushed too hard for too long, or perhaps the multitude of medical experiments wasn't always a great idea. Nevertheless, I was doing what felt correct during those so very many years.

    Here's a few photos from that last era, the months of 10% body fat, of deltoid striations and viciously vascular definition. Rowing crew for two to three hours per day, six days per week, boosted like a racehorse that never wants to stop.

    Looking back with analytical eyes, as perhaps a more informed observer, now knowing the very same month which transpired these photos — was the very same month this brain decided a tumour should begin to grow. It never stopped growing, changing, affecting everything. The vascular muscles atrophied, resumed their softness, and body fat gradually doubled. No more race-pace, no more endorphins, no more no more.

    That same month was the last time I rowed, the last time that magnet was able to hold it all together.

    #fitness #gym #endorphins #physique #womenshealth #medical #existentialism #tumour #braaaains

  24. Impressive new work by Moravec et al. in Nature Biotechnology, sadly not open source. "... a #HighThroughput personalized #TCR discovery pipeline ..." with which they "...identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific #neoantigens."

    nature.com/articles/s41587-024

    #cancer #tumour #Tcells
    #science

  25. Impressive new work by Moravec et al. in Nature Biotechnology, sadly not open source. "... a #HighThroughput personalized #TCR discovery pipeline ..." with which they "...identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific #neoantigens."

    nature.com/articles/s41587-024

    #cancer #tumour #Tcells
    #science

  26. Impressive new work by Moravec et al. in Nature Biotechnology, sadly not open source. "... a #HighThroughput personalized #TCR discovery pipeline ..." with which they "...identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific #neoantigens."

    nature.com/articles/s41587-024

    #cancer #tumour #Tcells
    #science

  27. Impressive new work by Moravec et al. in Nature Biotechnology, sadly not open source. "... a #HighThroughput personalized #TCR discovery pipeline ..." with which they "...identified dozens of CD4+ and CD8+ T-cell-derived TCRs with potent tumor reactivity, including TCRs that recognized patient-specific #neoantigens."

    nature.com/articles/s41587-024

    #cancer #tumour #Tcells
    #science

  28. #Tasmaniandevil facial #tumour hasn’t let up cosmosmagazine.com/nature/anim

    In 2021, a study showed that 25 years of #DFTD’s spread had a massive impact on the Tasmanian devil population. The number of devils on the island of Tasmania shrank from 53,000 in 1996 to only 17,000 in 2021. The same study suggested that DFTD covered more than 90% of the devils’ range in Tasmania. As a result, #Australia’s largest remaining marsupial carnivore was listed as endangered.

  29. #Tasmaniandevil facial #tumour hasn’t let up cosmosmagazine.com/nature/anim

    In 2021, a study showed that 25 years of #DFTD’s spread had a massive impact on the Tasmanian devil population. The number of devils on the island of Tasmania shrank from 53,000 in 1996 to only 17,000 in 2021. The same study suggested that DFTD covered more than 90% of the devils’ range in Tasmania. As a result, #Australia’s largest remaining marsupial carnivore was listed as endangered.

  30. #Tasmaniandevil facial #tumour hasn’t let up cosmosmagazine.com/nature/anim

    In 2021, a study showed that 25 years of #DFTD’s spread had a massive impact on the Tasmanian devil population. The number of devils on the island of Tasmania shrank from 53,000 in 1996 to only 17,000 in 2021. The same study suggested that DFTD covered more than 90% of the devils’ range in Tasmania. As a result, #Australia’s largest remaining marsupial carnivore was listed as endangered.

  31. #Tasmaniandevil facial #tumour hasn’t let up cosmosmagazine.com/nature/anim

    In 2021, a study showed that 25 years of #DFTD’s spread had a massive impact on the Tasmanian devil population. The number of devils on the island of Tasmania shrank from 53,000 in 1996 to only 17,000 in 2021. The same study suggested that DFTD covered more than 90% of the devils’ range in Tasmania. As a result, #Australia’s largest remaining marsupial carnivore was listed as endangered.

  32. #Tasmaniandevil facial #tumour hasn’t let up cosmosmagazine.com/nature/anim

    In 2021, a study showed that 25 years of #DFTD’s spread had a massive impact on the Tasmanian devil population. The number of devils on the island of Tasmania shrank from 53,000 in 1996 to only 17,000 in 2021. The same study suggested that DFTD covered more than 90% of the devils’ range in Tasmania. As a result, #Australia’s largest remaining marsupial carnivore was listed as endangered.

  33. Other than a prolactinoma, what other possible explanations are there for high prolactin and low testosterone in adult males?
    Am getting an MRI in a couple of hours to investigate but am curious.

    #health #brain #tumour #hormones

  34. Other than a prolactinoma, what other possible explanations are there for high prolactin and low testosterone in adult males?
    Am getting an MRI in a couple of hours to investigate but am curious.

    #health #brain #tumour #hormones

  35. Other than a prolactinoma, what other possible explanations are there for high prolactin and low testosterone in adult males?
    Am getting an MRI in a couple of hours to investigate but am curious.

    #health #brain #tumour #hormones

  36. Other than a prolactinoma, what other possible explanations are there for high prolactin and low testosterone in adult males?
    Am getting an MRI in a couple of hours to investigate but am curious.

    #health #brain #tumour #hormones

  37. Heute sind meine Schmerzen besonders schlimm.

    Ich weiß nicht warum.

    Lasse mir gleich ein Bonus geben von morphine. ;(

    #CancerResearch #cancer #tumour #Neurofibromatosi

  38. Anyone who supports me to pay for services and assistance that are not covered by insurance in order to at least take away my financial worries while fighting my cancer can do so here:

    My Amazon Wishlist:
    amazon.de/hz/wishlist/ls/MLYVB

    My GoFoundMe Page:
    gofund.me/bdc717c7

    My Paypal Account:
    paypal.com/pools/c/92opGMV4OB

    Of course and that would be much more appreciate if you like and share my posts.

    Thank you very much for any support.

    Roland

    #CancerResearch #cancer #tumour #Neurofibromatosis

  39. Anyone who supports me to pay for services and assistance that are not covered by insurance in order to at least take away my financial worries while fighting my cancer can do so here:

    My Amazon Wishlist:
    amazon.de/hz/wishlist/ls/MLYVB

    My GoFoundMe Page:
    gofund.me/bdc717c7

    My Paypal Account:
    paypal.com/pools/c/92opGMV4OB

    Of course and that would be much more appreciate if you like and share my posts.

    Thank you very much for any support.

    Roland

    #CancerResearch #cancer #tumour #Neurofibromatosis

  40. Anyone who supports me to pay for services and assistance that are not covered by insurance in order to at least take away my financial worries while fighting my cancer can do so here:

    My Amazon Wishlist:
    amazon.de/hz/wishlist/ls/MLYVB

    My GoFoundMe Page:
    gofund.me/bdc717c7

    My Paypal Account:
    paypal.com/pools/c/92opGMV4OB

    Of course and that would be much more appreciate if you like and share my posts.

    Thank you very much for any support.

    Roland

    #CancerResearch #cancer #tumour #Neurofibromatosis

  41. Anyone who supports me to pay for services and assistance that are not covered by insurance in order to at least take away my financial worries while fighting my cancer can do so here:

    My Amazon Wishlist:
    amazon.de/hz/wishlist/ls/MLYVB

    My GoFoundMe Page:
    gofund.me/bdc717c7

    My Paypal Account:
    paypal.com/pools/c/92opGMV4OB

    Of course and that would be much more appreciate if you like and share my posts.

    Thank you very much for any support.

    Roland

    #CancerResearch #cancer #tumour #Neurofibromatosis

  42. Anyone who supports me to pay for services and assistance that are not covered by insurance in order to at least take away my financial worries while fighting my cancer can do so here:

    My Amazon Wishlist:
    amazon.de/hz/wishlist/ls/MLYVB

    My GoFoundMe Page:
    gofund.me/bdc717c7

    My Paypal Account:
    paypal.com/pools/c/92opGMV4OB

    Of course and that would be much more appreciate if you like and share my posts.

    Thank you very much for any support.

    Roland

    #CancerResearch #cancer #tumour #Neurofibromatosis